Prognostic scoring systems for myelofibrosis
| . | DIPSS3 . | DIPSS plus38 . | MIPSS707 . | MIPSS70 plus . | MYSEC39 . |
|---|---|---|---|---|---|
| Age | ☑ | ☑ | ☑ | ☑ | ☑ |
| Anemia (hemoglobin <10) | ☑ | ☑ | ☑ | ☑ | ☑ |
| WBC >25 | ☑ | ☑ | ☑ | ||
| Blast % | ☑ | ☑ | ☑ | ☑ | ☑ |
| Constitutional symptoms | ☑ | ☑ | ☑ | ☑ | ☑ |
| Platelets <100 | ☑ | ☑ | ☑ | ||
| Red cell transfusion dependent | ☑ | ||||
| Unfavorable karyotype* | ☑ | ☑ | |||
| Bone marrow fibrosis grade | ☑ | ||||
| High-risk molecular mutations (1) | ☑ | ☑ | |||
| High-risk molecular mutations (≥2) | ☑ | ☑ | |||
| Type 1 CAL-R absence | ☑ | ☑ | |||
| Scoring | Low risk: 0 | Low: 0 | Low: 0-1 | Low: 0-2 | Low: <11 |
| Int-1: 1-2 | Int-1: 1 | Intermediate: 2-4 | Intermediate: 3 | Int-1: 11-13 | |
| Int-2: 3-4 | Int-2: 2-3 | High: ≥5 | High: 4-6 | Int-2: 14-16 | |
| High risk: 5-6 | High risk: 4-6 | Very high: ≥7 | High: >16 |
| . | DIPSS3 . | DIPSS plus38 . | MIPSS707 . | MIPSS70 plus . | MYSEC39 . |
|---|---|---|---|---|---|
| Age | ☑ | ☑ | ☑ | ☑ | ☑ |
| Anemia (hemoglobin <10) | ☑ | ☑ | ☑ | ☑ | ☑ |
| WBC >25 | ☑ | ☑ | ☑ | ||
| Blast % | ☑ | ☑ | ☑ | ☑ | ☑ |
| Constitutional symptoms | ☑ | ☑ | ☑ | ☑ | ☑ |
| Platelets <100 | ☑ | ☑ | ☑ | ||
| Red cell transfusion dependent | ☑ | ||||
| Unfavorable karyotype* | ☑ | ☑ | |||
| Bone marrow fibrosis grade | ☑ | ||||
| High-risk molecular mutations (1) | ☑ | ☑ | |||
| High-risk molecular mutations (≥2) | ☑ | ☑ | |||
| Type 1 CAL-R absence | ☑ | ☑ | |||
| Scoring | Low risk: 0 | Low: 0 | Low: 0-1 | Low: 0-2 | Low: <11 |
| Int-1: 1-2 | Int-1: 1 | Intermediate: 2-4 | Intermediate: 3 | Int-1: 11-13 | |
| Int-2: 3-4 | Int-2: 2-3 | High: ≥5 | High: 4-6 | Int-2: 14-16 | |
| High risk: 5-6 | High risk: 4-6 | Very high: ≥7 | High: >16 |
Unfavorable karyotype: Complex karyotype or one or two abnormalities that include +8, –7/7q–, i(17q), –5/5q–, 12p–, inv(3), or 11q23. High-Risk molecular mutations: ASXL1, IDH1/2, EZH2, SRSF2, and U2AF1.